MedPath

Microgestin Fe 1.5/30

Microgestin® Fe 1.5/30(Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*)*Ferrous fumarate tablets are not USP for dissolution.

Approved
Approval ID

1587721b-0d71-4fe7-9e34-eac41a115203

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 23, 2020

Manufacturers
FDA

Mayne Pharma Inc.

DUNS: 867220261

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51862-870
Application NumberANDA091453
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate
Product Specifications
Effective DateOctober 12, 2020
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Microgestin Fe 1.5/30 - FDA Drug Approval Details